Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Ambinder

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Current Opinion in Oncology|March 1, 1995
Epstein-Barr virus and bone marrow transplantationC Caldas, R Ambinder
Annals of Internal Medicine|June 1, 1984
Prophylactic acyclovir therapy and herpes simplexR Ambinder, W Burns, P Lietman, et al.
The Journal of Investigative Dermatology|July 1, 1984
Structural organization of human herpesvirus DNA moleculesG S Hayward, R Ambinder, D Ciufo, et al.
Oncology|January 26, 2002
Gemcitabine as first-line therapy in patients with metastatic breast cancer: a phase II trialM Blackstein, C L Vogel, R Ambinder, et al.
American Journal of Clinical Pathology|January 1, 1989
A survey of Epstein-Barr virus DNA in lymphoid tissue. Frequent detection in Hodgkin's diseaseS P Staal, R Ambinder, W E Beschorner, et al.
Genes, Chromosomes & Cancer|March 1, 1992
t(11;18)(q21;q21) is a recurrent chromosome abnormality in small lymphocytic lymphomaC A Griffin, B A Zehnbauer, W E Beschorner, et al.
Journal of Clinical Microbiology|February 13, 1999
PCR detection of adenovirus in a bone marrow transplant recipient: hemorrhagic cystitis as a presenting manifestation of disseminated diseaseM S Echavarria, S C Ray, R Ambinder, et al.
Journal of Hematotherapy|June 11, 1998
Feasibility of cellular adoptive immunotherapy for Epstein-Barr virus-associated lymphomas using haploidentical donorsR J Orentas, M V Lemas, M J Mullin, et al.
Epidemiology and Infection|December 14, 2011
Evidence of genetic susceptibility to infectious mononucleosis: a twin studyA E Hwang, A S Hamilton, M G Cockburn, et al.
Annals of Internal Medicine|October 1, 1984
Cefotaxime compared with nafcillin plus tobramycin for serious bacterial infections. A randomized, double-blind trialC R Smith, R Ambinder, J J Lipsky, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Current Opinion in Oncology|March 1, 1995
Epstein-Barr virus and bone marrow transplantationC Caldas, R Ambinder
Annals of Internal Medicine|June 1, 1984
Prophylactic acyclovir therapy and herpes simplexR Ambinder, W Burns, P Lietman, et al.
The Journal of Investigative Dermatology|July 1, 1984
Structural organization of human herpesvirus DNA moleculesG S Hayward, R Ambinder, D Ciufo, et al.
Oncology|January 26, 2002
Gemcitabine as first-line therapy in patients with metastatic breast cancer: a phase II trialM Blackstein, C L Vogel, R Ambinder, et al.
American Journal of Clinical Pathology|January 1, 1989
A survey of Epstein-Barr virus DNA in lymphoid tissue. Frequent detection in Hodgkin's diseaseS P Staal, R Ambinder, W E Beschorner, et al.
Genes, Chromosomes & Cancer|March 1, 1992
t(11;18)(q21;q21) is a recurrent chromosome abnormality in small lymphocytic lymphomaC A Griffin, B A Zehnbauer, W E Beschorner, et al.
Journal of Clinical Microbiology|February 13, 1999
PCR detection of adenovirus in a bone marrow transplant recipient: hemorrhagic cystitis as a presenting manifestation of disseminated diseaseM S Echavarria, S C Ray, R Ambinder, et al.
Journal of Hematotherapy|June 11, 1998
Feasibility of cellular adoptive immunotherapy for Epstein-Barr virus-associated lymphomas using haploidentical donorsR J Orentas, M V Lemas, M J Mullin, et al.
Epidemiology and Infection|December 14, 2011
Evidence of genetic susceptibility to infectious mononucleosis: a twin studyA E Hwang, A S Hamilton, M G Cockburn, et al.
Annals of Internal Medicine|October 1, 1984
Cefotaxime compared with nafcillin plus tobramycin for serious bacterial infections. A randomized, double-blind trialC R Smith, R Ambinder, J J Lipsky, et al.
Pageof 2